Future Trends Influencing the CD47 Targeting Therapeutics Market Worldwide
As the landscape of cancer treatment evolves, the CD47 Targeting Therapeutics Market Volume is positioned for a significant uptick. Projected to escalate from USD 2.41 billion in 2024 to a staggering USD 23.3 billion by 2035, this market demonstrates a compound annual growth rate (CAGR) of 22.89%. The escalating incidence of cancer, particularly in the United States, where over 1.9 million new...
0 Комментарии 0 Поделились 7 Просмотры 0 предпросмотр